C.Q. Pharmaceutical Holding Co., Ltd. (SHE:000950)
6.03
+0.03 (0.50%)
At close: Feb 6, 2026
SHE:000950 Revenue
C.Q. Pharmaceutical Holding had revenue of 21.02B CNY in the quarter ending September 30, 2025, with 5.57% growth. This brings the company's revenue in the last twelve months to 83.08B, up 4.23% year-over-year. In the year 2024, C.Q. Pharmaceutical Holding had annual revenue of 80.56B with 2.76% growth.
Revenue (ttm)
83.08B
Revenue Growth
+4.23%
P/S Ratio
0.13
Revenue / Employee
6.01M
Employees
13,820
Market Cap
10.42B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.56B | 2.16B | 2.76% |
| Dec 31, 2023 | 78.40B | 10.57B | 15.58% |
| Jan 1, 2023 | 67.83B | 5.31B | 8.49% |
| Dec 31, 2021 | 62.52B | 17.30B | 38.26% |
| Dec 31, 2020 | 45.22B | 11.38B | 33.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Pharmaceuticals Holding | 280.69B |
| Jointown Pharmaceutical Group | 157.71B |
| Guangzhou Baiyunshan Pharmaceutical Holdings Company | 77.54B |
| China National Accord Medicines Corporation | 73.04B |
| China National Medicines Corporation | 51.95B |
| China Meheco Group | 33.23B |
| Guangxi LiuYao Group | 20.95B |
| Liaoning Cheng Da | 11.12B |